GSK launched Zantac in 1981 and it was first approved ... The court case has dogged the company’s share price for a number of years and the sharp rise today comes as no surprise.
The first lawsuit claiming that gastrointestinal drug Zantac causes cancer has been voluntarily dismissed a week before it was due to come to trial, in an early victory for the pharma companies ...
GSK is among a number of companies that made and sold versions of Zantac, and investor concern about the potential settlement value has weighed heavily on the drugmaker’s share price.
Concerns over Zantac have been blamed for keeping GSK’s share price depressed at a time of booming sales and profits at the British drugmaker. Earlier this year almost £7bn was wiped off GSK ...
GSK is among a number of companies that made and sold versions of Zantac, and investor concerns about the potential settlement value has weighed heavily on the drugmaker’s share price.
GSK said total sales fell by two per cent in the third quarter Pharmaceutical giant GSK has reported a drop in profit due to charges related to the Zantac lawsuits but has reaffirmed guidance and ...
GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The British drugmaker’s settlement ...
Commissions do not affect our editors' opinions or evaluations. The price of gold today, as of 8:17 am ET, was $2,691 per ounce. That’s down 0.57% from yesterday’s gold price of $2,706.